CLINARIS cooperates now with Roche Diagnostics


CLINARIS signs collaboration agreement with Roche Diagnostics and joins cobas® pulse point-of-care ecosystem

CLINARIS GmbH has announced a cooperation agreement with Roche Diagnostics to integrate its intelligent digitalisation solution HPM® into the cobas® pulse point-of-care ecosystem. HPM® provides a real-time view of the location, hygienic and technical status as well as the useful life of medical devices. The solution can communicate with common facility management and logistics systems and can be installed within a few weeks. By integrating HPM® with cobas® pulse, caregivers can see the exact location and status of the medical devices they need and are guided to the next available option. Cleaning staff and technical staff also benefit from the solution. HPM® enables reporting of defects and labelling of contaminated products to ensure appropriate cleaning. The occurrence of contaminated medical devices is reported in real time and the solution creates digital documentation of cleaning cycles. The integration of HPM® into the cobas® pulse ecosystem facilitates access to the digital solution for caregivers. The goal is to improve efficiency and safety in healthcare and combat nosocomial infections. cobas® pulse is a networked blood glucose management solution from Roche that, together with cobas® infinity edge software, forms an open digital ecosystem. More information is available on the cobas® infinity edge and cobas® pulse websites.

HPM® auf cobas® pulse vereinfacht Arbeitsabläufe und verbessert die Zusammenarbeit zwischen Pflege, Hygiene, Medizintechnik und Reinigung
HPM® on cobas® pulse simplifies workflows and improves collaboration between nursing, hygiene, medical technology and cleaning

About CLINARIS

CLINARIS GmbH was founded in 2014. The headquarters are located in Garching near Munich. HPM® is an intelligent digital solution for safe and efficient cooperation between nursing, hygiene, medical technology, cleaning and controlling. HPM® documents the reprocessing process of medical devices in real time and shows their exact location, hygiene and technical status as well as the actual duration of use. More information at www.clinaris.com

Contact:

CLINARIS GmbH
Thorsten Amann
Lichtenbergstraße 8
85748 Garching b. Munich

T +49 (0)89 21 53 870-0

Future market refrigeration, air conditioning and ventilation

c23 ventures invests in an innovative company in the future market of refrigeration, air conditioning and ventilation technology.

With a sustainable growth strategy, the company will become a leading group of companies in the future market of refrigeration, air conditioning and ventilation technology. To achieve this, the company is taking over renowned local businesses with the aim of successful joint business development or smooth company succession.

Modern air conditioning device. There is a big market growth in Europe expected. Foto: Jonathan Borba Pexels

The local group company can and should concentrate entirely on day-to-day business. Administrative tasks are a thing of the past and will be taken over by companies in the future.

All3DP with new growth financing

Over the years c23 ventures invest All3DP GmbH in Munich, Germany has grown with the trend of 3D printers. CEO Matthias Plica has no worries about large suppliers such as Google or Amazon getting involved in the component business. “We are currently in a pleasant but global niche,” says the co-founder, “and at the same time in a market that is fortunately not so trivial. In order to maintain its lead, the start-up company has just completed a financing round. More than two million euros are being provided by existing investors.

3D Printing filaments are available in different colors.

The current funding is therefore only an intermediate step for All3DP. Next year, the start-up company wants to raise money again – with the participation of international investors. “The role of 3D printing in the production of physical goods is becoming increasingly important,” says Plica, “opening up access to a market volume of over 12 trillion euros.

See a full report in German Language at Wirtschaftswoche.

c23 ventures invests in digital talent analysis tool

Aivy revolutionises recruiting with focus on individual strengths

Aivy, a pioneer in the field of recruiting, has a vision of a working world that focuses on the person behind the CV. The company believes that individual strengths have the greatest predictive power for job success and satisfaction and should therefore play a central role in recruiting. By implementing this vision, each talent is placed in the right job and can develop their full potential.

Furthermore, this focus on individual strengths contributes to social sustainability. Companies have the opportunity to successfully assemble diverse teams to tackle the challenges of our time together.

Talent analysis for the modern HR management with Aivy. Photo: Aivy

With its game-based assessments, Aivy has developed an innovative solution to support talents in discovering their individual strengths. At the same time, these assessments enable HR managers to make efficient, objective and successful selection decisions by quickly identifying suitable applicants. The assessments are based on psychological science and are characterised by their short duration, which leads to a strong candidate experience and at the same time enables time savings of up to 80%.

Aivy thus revolutionises the recruiting process and creates a win-win situation for talents and companies. By bringing individual strengths to the forefront, it enables a custom-fit placement that leads to higher job satisfaction and performance.

For more information about Aivy and the game-based assessments, please visit their website.

Pumpergsund investment convinces with “Climate-Egg”: 27% better than an organic egg

Scurrying about in the shelter of forests, jumping into the treetops, taking a dust-bath in the shade and picking organic fodder: a start-up from Munich proves that animal welfare, climate and environmental protection are compatible with profitable food production. The result: The Climate Egg. And it is under this name that the company Pumperlgsund brings the organic eggs with a special ecological footprint to German supermarkets at Easter.
The forest chickens: 365 days a year the chickens can go into the forest

(Photo: Pumperlgsund)

The happy chickens in the video: https://youtu.be/GXdxCmhvOJo
The international Eaternity Institute has measured the ecological footprint of egg production, including transport to retailers. The study revealed: 11 out of 12 possible points. The Climate Egg had to prove itself for the Eaternity Score in four categories: animal welfare, environment, rainforest and water.
And the evaluation results are impressive:
The Climate Change Egg has a 27% better carbon footprint than the average organic egg (EU
organic) – and is 47 % better than the free-range egg.
The production of six Klima-Egg consumes only 26 litres of water.
The entire value chain produces only 857 grams of CO2 – for normal organic eggs it is over 1,000 grams.